24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioGenCell
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:09
eToro tops $5.5 billion valuation as shares surge on Nasdaq debut
19:32
Trump's Riyadh party went on without Israel. Can it still join fashionably late?
15:22
"The opportunity to help customers has changed dramatically because of AI"
14:32
"AI does not replace people, it replaces tasks"
More stories
Buzz
Most popular
Daily
Weekly
1
IBM’s Red Hat acquires stealth Israeli startup Jounce for $20M to bolster AI cloud stack
2
Defense startup Kela raises $60 million, reaches $100 million in first-year funding
3
eToro’s IPO raises $620M as it begins trading on Nasdaq today
4
The 50 most promising Israeli startups - 2025
5
Nebius to build Israel’s AI supercomputer
More news
BioGenCell
1 stories about BioGenCell
BioGenCell pioneers revolutionary cell therapy for microvascular disease
11.07.24
|
Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation
